MedTrace Logo

A Multi-centre Study to Assess the Long-term Performance of the Silent Hip™ in Primary Total Hip Replacement Surgery

NCT01383824 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2016-05-27

No results posted yet for this study

Summary

The purpose of this study is to monitor the performance and of the Silent Hip™ in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.

Conditions

  • Primary Arthritis
  • Secondary Arthritis

Interventions

DEVICE

Silent™ Hip

A short cementless, femoral component for use in total hip arthroplasty

Sponsors & Collaborators

  • DePuy International

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-07-31
Completion
2015-07-31

Countries

  • Denmark
  • Germany
  • Italy
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01383824 on ClinicalTrials.gov